Georgia L. Erbez
Net Worth

Last updated:

What is Georgia L. Erbez net worth?

The estimated net worth of Ms. Georgia L. Erbez is at least $3,327,300 as of 22 Sep 2021. She has received compensation worth at least $3,327,300 in Harpoon Therapeutics, Inc..

What is the salary of Georgia L. Erbez?

Ms. Georgia L. Erbez salary is $554,550 per year as Chief Financial Officer in Harpoon Therapeutics, Inc..

How old is Georgia L. Erbez?

Ms. Georgia L. Erbez is 58 years old, born in 1967.

What stocks does Georgia L. Erbez currently own?

As insider, Ms. Georgia L. Erbez owns shares in one company:

Company Title Shares Price per share Total value
Harpoon Therapeutics, Inc. (HARP) Chief Financial Officer 19,215 $0 $0

What does Harpoon Therapeutics, Inc. do?

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic cancer, and other mesothelin-expressing tumors. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

HARP logo
HARP
Harpoon Therapeutics, Inc.

Georgia L. Erbez insider trading

Harpoon Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 10,300 $8.1 $83,430
Option
Common Stock 25,000 N/A N/A
Option
Employee Stock Option (right to buy) 25,000 $2.12 $53,000
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 2,098 $11.6 $24,337
Purchase
Common Stock 1,817 $10.92 $19,842
Purchase
Common Stock 6,700 N/A N/A
Option
Common Stock 47,292 N/A N/A
Option
Employee Stock Option (right to buy) 47,292 N/A N/A

Harpoon Therapeutics key executives

Harpoon Therapeutics, Inc. executives and other stock owners filed with the SEC: